![Maria Siemionow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Siemionow
Fundador en
Dystrogen Therapeutics Corp.
.
Perfil
Maria Siemionow founded Tolera Therapeutics, Inc. in 2007, where she worked as Chief Science Technology Officer and Dystrogen Therapeutics Corp.
in 2017, where she is working as Chief Scientific Officer from 2017.
Cargos activos de Maria Siemionow
| Empresas | Cargo | Inicio |
|---|---|---|
Dystrogen Therapeutics Corp.
 Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Develops platform for personalized therapies for rare genetic diseases | Fundador | 01/01/2017 |
Antiguos cargos conocidos de Maria Siemionow.
| Empresas | Cargo | Fin |
|---|---|---|
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
3
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Commercial Services |
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Develops platform for personalized therapies for rare genetic diseases | Technology Services |
- Bolsa de valores
- Insiders
- Maria Siemionow
